Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease. [electronic resource]
- Journal of neurology, neurosurgery, and psychiatry Dec 1999
- 737-41 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-3050
10.1136/jnnp.67.6.737 doi
Aged Binding, Competitive--physiology Biological Transport, Active--physiology Brain--diagnostic imaging Caudate Nucleus Corpus Striatum--metabolism Disability Evaluation Dopamine--metabolism Female Fluorodeoxyglucose F18 Follow-Up Studies Humans Ligands Male Middle Aged Parkinson Disease--diagnosis Putamen--metabolism Radiopharmaceuticals Severity of Illness Index Substantia Nigra--metabolism Tomography, Emission-Computed